These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 22836204)

  • 1. Biological variation in tPA-induced plasma clot lysis time.
    Talens S; Malfliet JJ; Rudež G; Spronk HM; Janssen NA; Meijer P; Kluft C; de Maat MP; Rijken DC
    Thromb Haemost; 2012 Oct; 108(4):640-6. PubMed ID: 22836204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered plasma fibrin clot properties in essential thrombocythemia.
    Małecki R; Gacka M; Kuliszkiewicz-Janus M; Jakobsche-Policht U; Kwiatkowski J; Adamiec R; Undas A
    Platelets; 2016; 27(2):110-6. PubMed ID: 25989112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin clot properties in women heterozygous for factor V Leiden mutation: effects of oral contraceptives.
    Krzek M; Ciesla-Dul M; Zabczyk M; Undas A
    Thromb Res; 2012 Oct; 130(4):e216-21. PubMed ID: 22940058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clot lysis time in platelet-rich plasma: method assessment, comparison with assays in platelet-free and platelet-poor plasmas, and response to tranexamic acid.
    Panes O; Padilla O; Matus V; Sáez CG; Berkovits A; Pereira J; Mezzano D
    Platelets; 2012; 23(1):36-44. PubMed ID: 21787173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A history of early stent thrombosis is associated with prolonged clot lysis time.
    Pankiw-Bembenek O; Zalewski J; Goralczyk T; Undas A
    Thromb Haemost; 2012 Mar; 107(3):513-20. PubMed ID: 22274545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced plasma fibrinolytic capacity as a potential risk factor for a first myocardial infarction in young men.
    Meltzer ME; Doggen CJ; de Groot PG; Rosendaal FR; Lisman T
    Br J Haematol; 2009 Apr; 145(1):121-7. PubMed ID: 19170679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered plasma fibrin clot properties in patients with digestive tract cancers: links with the increased thrombin generation.
    Gronostaj K; Richter P; Nowak W; Undas A
    Thromb Res; 2013 Mar; 131(3):262-7. PubMed ID: 23273404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unfavorably altered fibrin clot properties in patients with active rheumatoid arthritis.
    Kwasny-Krochin B; Gluszko P; Undas A
    Thromb Res; 2010 Jul; 126(1):e11-6. PubMed ID: 20471669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged clot lysis time increases the risk of a first but not recurrent venous thrombosis.
    Karasu A; Baglin TP; Luddington R; Baglin CA; van Hylckama Vlieg A
    Br J Haematol; 2016 Mar; 172(6):947-53. PubMed ID: 26773756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypofibrinolysis is a risk factor for arterial thrombosis at young age.
    Guimarães AH; de Bruijne EL; Lisman T; Dippel DW; Deckers JW; Poldermans D; Rijken DC; Leebeek FW
    Br J Haematol; 2009 Apr; 145(1):115-20. PubMed ID: 19183334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prothrombotic fibrin clot properties associated with NETs formation characterize acute pulmonary embolism patients with higher mortality risk.
    Ząbczyk M; Natorska J; Janion-Sadowska A; Metzgier-Gumiela A; Polak M; Plens K; Janion M; Skonieczny G; Mizia-Stec K; Undas A
    Sci Rep; 2020 Jul; 10(1):11433. PubMed ID: 32651425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clot lysis time and the risk of myocardial infarction and ischaemic stroke in young women; results from the RATIO case-control study.
    Siegerink B; Meltzer ME; de Groot PG; Algra A; Lisman T; Rosendaal FR
    Br J Haematol; 2012 Jan; 156(2):252-8. PubMed ID: 22082241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A precise and rapid microtitre plate clot lysis assay: methodology, kinetic modeling and measurement of catalytic constants for plasminogen activation during fibrinolysis.
    Jones AJ; Meunier AM
    Thromb Haemost; 1990 Nov; 64(3):455-63. PubMed ID: 2128976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of recurrent venous thromboembolism by clot lysis time: a prospective cohort study.
    Traby L; Kollars M; Eischer L; Eichinger S; Kyrle PA
    PLoS One; 2012; 7(12):e51447. PubMed ID: 23240024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of plasmin generation and clot lysis of plasma fibrinogen purified from a heterozygous dysfibrinogenemia, BbetaGly15Cys (Hamamatsu II).
    Kamijyo Y; Hirota-Kawadobora M; Yamauchi K; Terasawa F; Honda T; Ikeya M; Okumura N
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):726-32. PubMed ID: 19809304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
    Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A hypercoagulable and hypofibrinolytic state is detectable by global methods in patients with retinal vein occlusion.
    Cellai AP; Lami D; Fedi S; Marcucci R; Mannini L; Cenci C; Rogolino A; Sodi A; Menchini U; Abbate R; Prisco D
    Atherosclerosis; 2012 Sep; 224(1):97-101. PubMed ID: 22800650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term effects of air temperature on blood markers of coagulation and inflammation in potentially susceptible individuals.
    Schäuble CL; Hampel R; Breitner S; Rückerl R; Phipps R; Diaz-Sanchez D; Devlin RB; Carter JD; Soukup J; Silbajoris R; Dailey L; Koenig W; Cyrys J; Geruschkat U; Belcredi P; Kraus U; Peters A; Schneider AE
    Occup Environ Med; 2012 Sep; 69(9):670-8. PubMed ID: 22833664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A plasma clot lysis assay based on the release of fibrin degradation products: application to the diagnosis of hypofibrinolytic states.
    Gaussem P; Gandrille S; Molho-Sabatier P; Capron L; Fiessinger JN; Aiach M
    Thromb Haemost; 1990 Feb; 63(1):76-81. PubMed ID: 2111050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of European population levels of thrombotic and inflammatory factors with risk of coronary heart disease: the MONICA Optional Haemostasis Study.
    Yarnell J; McCrum E; Rumley A; Patterson C; Salomaa V; Lowe G; Evans A
    Eur Heart J; 2005 Feb; 26(4):332-42; discussion 317-8. PubMed ID: 15618045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.